Acute myocardial ischaemia and cardiogenic shock after percutaneous transluminal coronary angioplasty; risk factors for and results of emergency coronary bypass

Between 1 September, 1980 and 1 January, 1989, 4142 patients underwent percutaneous transluminal coronary angioplasty (PTCA). We retrospectively studied the 155 [3·7%; 119 males, mean age 53·4 years, (range 33–78 years) and 36 females, mean age 59·6 years (range 40–74 years) ] who required urgent co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 1989-12, Vol.10 (suppl-H), p.104-111
Hauptverfasser: Bredée, J. J., Bavinck, J. H., Berreklouw, E., Bonnier, H. J., van Doorn, C., El Gamal, M. I., Hendel, P. N., Mashhour, Y. A., Michels, H. R., Relik, T. H., Schönberger, J. P., Steenbrink, J., van Wandelen, R. N., Ter Woorst, F. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Between 1 September, 1980 and 1 January, 1989, 4142 patients underwent percutaneous transluminal coronary angioplasty (PTCA). We retrospectively studied the 155 [3·7%; 119 males, mean age 53·4 years, (range 33–78 years) and 36 females, mean age 59·6 years (range 40–74 years) ] who required urgent coronary artery bypass grafting (CABG) (Group I) and a select control group of 155 patients, in whom PTCA was performed without complications (Group II). Before PTCA, 14 Group I and 42 Group II patients had angina Class II, and 78 Group I and 49 Group II patients had angina class IV (X2-test, P < 0·05). There were 445 complications in the 155 group I patients: 303 (68%) early (during PTCA) and 141 (32%) late (within24 h). Onarrivalin the operating room 126 patients were stable;five were in cardiac arrest and 19 in cardiogenic shock (AS-group; 24 patients). In the AS-group and control group, respectively, angina Class II occurred in 2/24 (8·3%) and 42/155 (27·1%) patients, angina Class IV in 14/24 (58·3%) and49/155 (31·6%) (P
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/10.suppl_H.104